Literature DB >> 1458788

Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis.

M J van der Veen1, J W Bijlsma.   

Abstract

A clinical study of 30 patients with rheumatoid arthritis was undertaken in order to assess the acute effects of corticosteroids on calcium and bone metabolism. The patients were randomly divided into 3 groups. The first group was not treated with corticosteroids, the second group was treated with 3 oral pulses of 100 mg prednisolone and the third group received 3 intravenous pulses of 1000 mg methylprednisolone (MP) on alternate days during one week. In both steroid treated groups the serum parathyroid hormone concentration tended to increase. In the MP treated group an increase in the 1,25-dihydroxyvitamin D concentration after the first pulse was followed by a significant drop; this effect was also seen, but somewhat retarded and less distinct, in the orally treated group. In the MP treated group the urinary calcium excretion raised significantly 6 hrs after the first pulse and then dropped significantly. In all groups no changes were found in the serum calcium level and the urinary excretion of hydroxyproline. We conclude that, acute changes in calcium and bone metabolism occur during treatment with intravenous pulses of methylprednisolone and with oral pulses of prednisolone. These changes are small and reversible in a few days.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458788     DOI: 10.1007/bf02207199

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

Review 2.  Osteoporosis and arthritis.

Authors:  J Dequeker; P Geusens
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 3.  Bone metabolism in patients with rheumatoid arthritis.

Authors:  J W Bijlsma
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

4.  Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.

Authors:  J W Bijlsma; S A Duursma; R Bosch; J A Raymakers; O Huber-Bruning
Journal:  Br J Rheumatol       Date:  1988-06

5.  The determination of total hydroxyproline in urine and bone extracts.

Authors:  H E Firschein; J P Shill
Journal:  Anal Biochem       Date:  1966-02       Impact factor: 3.365

6.  Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.

Authors:  J W Bijlsma; S A Duursma; O Huber-Bruning
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

7.  Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.

Authors:  J W Findling; N D Adams; J Lemann; R W Gray; C J Thomas; J B Tyrrell
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

8.  Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia.

Authors:  J W Bijlsma; J A Raymakers; C Mosch; A Hoekstra; R H Derksen; H Baart de la Faille; S A Duursma
Journal:  Clin Exp Rheumatol       Date:  1988 Apr-Jun       Impact factor: 4.473

9.  Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay.

Authors:  A W Lindall; J Elting; J Ells; B A Roos
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

10.  Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.

Authors:  R Bouillon; E Muls; P De Moor
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more
  7 in total

Review 1.  Glucocorticoid-induced osteoporosis: who to treat with what agent?

Authors:  René Rizzoli; Emmanuel Biver
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

2.  Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.

Authors:  G Haugeberg; B Griffiths; K B Sokoll; P Emery
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  Assessment of bone mineral density by dual x-ray absorptiometry in dermatological patients treated by corticosteroids.

Authors:  Dorria Salem; Soha Talaat; Mona R E Abdel-Halim; Kareem Mohammed Mohsen
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

4.  Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2012-09-02       Impact factor: 2.980

5.  Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.

Authors:  Joanna Rymuza; Klaudia Gutowska; Dagmara Kurpios-Piec; Marta Struga; Piotr Miśkiewicz
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

6.  Site-Specific Variations in Bone Mineral Density under Systemic Conditions Inducing Osteoporosis in Minipigs.

Authors:  Matthias C Schulz; Jan Kowald; Sven Estenfelder; Roland Jung; Eberhard Kuhlisch; Uwe Eckelt; Ronald Mai; Lorenz C Hofbauer; Christian Stroszczynski; Bernd Stadlinger
Journal:  Front Physiol       Date:  2017-06-20       Impact factor: 4.566

7.  Holocene fluctuations in human population demonstrate repeated links to food production and climate.

Authors:  Andrew Bevan; Sue Colledge; Dorian Fuller; Ralph Fyfe; Stephen Shennan; Chris Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-20       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.